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Available online 28 August 2016Taenia solium is found throughout sub-SaharanAfrica and co-endemicwith schistosomiasis inmany
regions. Taenia solium leads to taeniosis andneurocysticercosis - the leading cause of preventable ep-
ilepsy globally. This study aimed to assess the effects of the National Schistosomiasis Control Pro-
gramme on prevalence of taeniosis and porcine cysticercosis over a four year period in Tanzania.
School-based mass drug administration (MDA) of praziquantel was carried out based on schistoso-
miasis endemicity. Four human and ﬁve porcine cross-sectional surveys were carried out from 2012
to 2015 inMbozi andMbeya district in Tanzania. Three rounds of school-basedMDA of praziquantel
were delivered inMbozi and two inMbeya. Theprevalence of taeniosis andporcine cysticercosiswas
estimated annually. Stool samples were collected from humans and prevalence of taeniosis estimat-
ed by copro-Ag-ELISA. Blood samples from pigs were collected to estimate cysticercosis prevalence
by Ag-ELISA. “Track-and-treat” of taeniosis cases was carried out after each survey. In total 12082
stool samples and 4579 porcine serum samples were collected. Signiﬁcantly fewer children (≤15)
fromMboziwere infected throughout the study than children fromMbeyawho showed a signiﬁcant
decrease in copro-Ag prevalence after the ﬁrst treatment only. During the ﬁnal survey in Mbozi the
prevalence of taeniosis in adults (1.8%) was signiﬁcantly lower (p = 0.031, OR 0.40, CI: 0.17–0.89),
compared to baseline (4.1%). The prevalence of porcine cysticercosis (8%) had also dropped signiﬁ-
cantly (p= 0.002,OR0.49, CI: 0.32–0.76) in this district compared tobaseline (13%),whereas no sig-
niﬁcant differencewas seen inMbeya compared to baseline. The study suggests that three rounds of
MDA targeting schistosomiasis in school-aged children combined with ‘track-and-treat’ contributed
to a reduction in prevalence of T. solium in this population, and also had a spillover effect on adults in
treated areas as well as reducing the prevalence of T. solium in the intermediate pig host population.
Elimination of T. solium in this area would require a One Health approach.
© 2016 The Authors. Published by Elsevier Ltd on behalf of World Federation of Parasitologists.
This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Preventive chemotherapytd on behalf of World Federation of Parasitologists. This is an open access article under the CC BY license
246 U.C. Braae et al. / Parasite Epidemiology and Control 1 (2016) 245–2511. Introduction
The zoonotic tapeworm Taenia solium is prevalent throughout sub-Saharan Africa (Braae et al., 2015c), and constitutes a seri-
ous, but preventable, agricultural and public health problem. In 1993 T. solium taeniosis/cysticercosis was declared eradicable by
the International Task Force on Disease Eradication (ITFDE), but to date no large-scale control programmes have been implement-
ed in sub-Saharan Africa. A larger scale initiative to eliminate T. solium has recently been trialled in Peru (Garcia et al., 2016). Due
to the zoonotic properties of T. solium, a cross-disciplinary One Health approach involving both the agricultural sector and the
human health sector, targeting both human and porcine hosts is likely to be essential to eliminate the parasite. Models have
shown prevalence to revert shortly after intervention targeting only one host (Kyvsgaard et al., 2007).
Schistosomiasis is found throughout sub-Saharan Africa and co-endemic in many areas with T. solium taeniosis/cysticercosis
(Braae et al., 2015c). National scale control programmes targeting schistosomiasis have been implemented in over 30 African
countries. In Tanzania the National Schistosomiasis Control Programme (NSCP) carries out school based MDA with praziquantel
at 40 mg/kg. The frequency of administration is dependent on the prevalence of schistosomiasis, in accordance with WHO guid-
ance. Praziquantel is also considered efﬁcacious against taeniosis at a dose of 5–10 mg/kg (Pawlowski, 1991). Therefor there is
potential for MDA using praziquantel on both helminth species.
This study aimed to investigate the impact of a school based NSCP on taeniosis and porcine cysticercosis by assessing the effect
of repeated rounds of praziquantel MDA at 40 mg/kg in combination with treatment of taeniosis cases identiﬁed during the study,
in two areas co-endemic for T. solium taeniosis/cysticercosis and schistosomiasis.
2. Materials and methods
2.1. Study design
The study consisted of multiple cross-sectional surveys carried out in the two districts Mbeya and Mbozi in Tanzania from
2012 to 2015 (Fig. 1). MDA of praziquantel at 40 mg/kg to school-aged children were carried out three times in Mbozi district
and twice in Mbeya district by the NSCP.
Stool samples were collected in 14 villages from the human population and has been described elsewhere (Braae et al.,
2015b), except for an additional survey preformed in July/August 2015 using identical methodology. Serum samples were collect-
ed from pigs in 22 villages and has also been described elsewhere (Braae et al., 2014), with the exception of the last two surveys
carried out in July/August 2014 and July/August 2015 using identical methodology (Fig. 2).
2.2. Data collection and ELISA analyses
During each survey approximately 1500 humans and 400 pigs were targeted in each district. Human stool samples were
analysed for taeniosis using the copro-Ag-ELISA (Allan et al., 1990; Mwape et al., 2012). Porcine serum samples were analysed
for cysticercosis using the B158/B60 Ag-ELISA (Brandt et al., 1992; Sikasunge et al., 2007).
2.3. Ethical considerations
The National Institute for Medical Research (NIMR) in Tanzania approved the study, reference number NIMR/HQ/R.8a/Vol. IX/
1216 as did the Imperial College Research Ethics Committee (ICREC), reference no. ICREC_11_3_6. Permission to conduct the study
was also sought through Sokoine University of Agriculture in Morogoro, Tanzania, in addition to regional, district, and local village
authorities. All treatments were carried out and overseen by the NTD secretariat of the Ministry of Health, Community Develop-
ment, Gender, Elderly and Children. Prior to each survey involving humans, study villages were visited and the communitiesFig. 1. Study design covering surveys (S) at month-0 (S0) to month-36 follow-up (S36) from 2012 to 2015 in Mbeya and Mbozi district, Tanzania. “Track-and-
treat” was attempted on all taeniosis cases identiﬁed during the study period.
Fig. 2. Map of study area, Mbeya and Mbozi district in Tanzania, showing where human stool and porcine blood samples were collected in the period 2012 to
2015.
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information about the study. Written informed consent was obtained from all participants in the human part of the study after
they were informed about the aim, risks, and beneﬁts of the study. If the person was under 18, consent was sought from a parent
or guardian following assent from the child. After each survey, and upon receiving the laboratory results of the copro-Ag-ELISA,
villages in the study area were visited, and village leaders, school headmasters, and head teachers were informed about the results
of the survey. Copro-Ag-ELISA positive individuals were offered anthelminthic treatment, either a single dose of 2 g niclosamide
for adults and 50 mg/kg for children or praziquantel at 10 mg/kg, within 5–8 months of sample collection. Forms to report side-
effects of the MDA were distributed to schools in the study villages and all individuals treated during the ‘track and treat’ were
provided with a contact number to a medical doctor in case of side-effects. All animals were handled in strict accordance with
good animal practice as deﬁned by the OIE's Terrestrial Animal Health Code for the use of animals in research and education.
Oral consent for porcine blood collection was sought from the farmer after information about the aim, risks, and beneﬁts of
the study were provided. Pigs found positive for T. solium cysticercosis, were treated at the subsequent visit with oxfendazole
(30 mg/kg) using an oral drench gun with synanthic 9.06 suspension, Merial, France, (batch no. F10701B). Owners of treated
pigs were instructed both orally and in writing that the pork was unﬁt for human consumption if the pig was slaughtered within
28 days of treatment with oxfendazole.2.4. Statistical methods
Human survey data were entered into EPI info 7 (http://wwwn.cdc.gov/epiinfo/7/) and transferred to an Excel spread sheet
(Microsoft Ofﬁce Excel 2010®). Porcine survey data was entered directly into an Excel spread sheet (Microsoft Ofﬁce Excel
2010®). All statistical analyses were performed in R (R Core Team 2015). Variables in the logistical regression were considered
signiﬁcant if the p-value was b0.05. Odds ratios (OR) and 95% conﬁdence intervals (CI) are provided for signiﬁcant variables.
All analyses were performed using the full dataset from 2012 to 2015 on both porcine and human surveys (Braae et al., 2014;
Braae et al., 2015b).2.5. Role of the funding source
The funder of the study had no role in design of the study, no access to the data, and did not participate in the analyses, in-
terpretation, writing, or decision to submit the manuscript. The corresponding author had access to all the data and is responsible
for the decision to submit the manuscript for publication.
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3.1. Taeniosis survey
In total 3018 stool samples from S36 were analysed for copro-antigens in the two districts (Table 1). During the whole study
period from 2012 to 2015, 12082 stool samples were collected and analysed for taeniosis. Based on logistic regressions with base-
line data (S0) from Braae et al. (2015b) as reference and controlling for sex and age, children (≤15 years) in Mbozi, the area that
had received MDA three times, had signiﬁcantly decreased odds of being infected at S12 (p = 0.005, OR 0.12, CI: 0.02–0.42), S24
(p = 0.001, OR 0.24, CI: 0.10–0.55), and S36 (p = 0.002, OR 0.04, CI: 0.01–0.21), and a drop in prevalence from 2.3% (Braae et al.,
2015b) to 0.1%. The identical analysis for children (≤15 years) from Mbeya, the area that had only received treatment twice,
showed only a signiﬁcant decrease from baseline (S0) after the ﬁrst round of MDA at S12 (p = 0.036, OR 0.20, CI: 0.03–0.74).
Among the children in Mbeya, decreasing age was associated with increased odds of taeniosis infection (p b 0.001, OR 0.70, CI:
0.59–0.82). Adults in Mbozi had gradual decreasing odds of infection at each subsequent time point, but odds were only signiﬁ-
cantly different from baseline after three rounds of MDA at the last time point (S36) (p = 0.031, OR 0.40, CI: 0.17–0.89), where
prevalence had dropped from 4.1% (Braae et al., 2015b) to 1.8%. In the adult population increasing age (p = 0.026, OR 1.02, CI:
1.00–1.04) and being male (p = 0.028, OR 1.83, CI: 1.08–3.18) was signiﬁcantly associated with infection in Mbozi. No signiﬁcant
difference was seen among the adults in Mbeya in any of the surveys, but age was associated with infection (p = 0.034, OR 1.03,
CI: 1.00–1.06).
Approximately ﬁve months after the 24 month time point (S24) all positive taeniosis cases, 12 in Mbozi and eight in Mbeya,
were “tracked-and-treated” with praziquantel at 10 mg/kg. Five months after the ﬁnal survey (S36) 15 out of the 16 positive in-
dividuals were treated during “track-and-treat” with 2 g niclosamide for adults and 50 mg/kg for children. It was not possible to
quantify the effect of the “track-and-treat” strategy. Although sample sizes were relative small the results indicate that taeniosis is
prevalent among older individuals (Fig. 3) which was also supported by the logistical regression analysis. No side-effects were re-
ported during the study period from any of the schools or individuals treated during the study.
3.2. Porcine cysticercosis surveys
In each district N400 pigs were sampled during each of the ﬁve surveys (Table 2). During the whole study period from 2012 to
2015, 4579 porcine blood samples were collected and analysed for porcine cysticercosis. The prevalence of porcine cysticercosis
increased in both districts signiﬁcantly after the ﬁrst three months. Potential causes of this increase in prevalence have been pre-
sented elsewhere (Braae et al., 2014). There was no difference in the proportion of pigs being kept conﬁned during the study pe-
riod within each district, but signiﬁcantly more pigs were kept conﬁned in Mbeya compared to Mbozi at each time point (Table
2).
Compared to the baseline (Fig. 4), a signiﬁcant decrease in prevalence (13% to 8%) of porcine cysticercosis (p = 0.002, OR 0.49,
CI: 0.32–0.76) was reported in Mbozi at the 36-month time point (S36) after three rounds of MDA. For Mbozi district, also the age
of the pigs were found to be a signiﬁcant risk factor of disease (p b 0.001, OR 1.04, CI: 1.02–1.06). No risk factors were identiﬁed
for Mbeya district.
3.3. Taeniosis and porcine cysticercosis
The relationship between taeniosis and porcine cysticercosis is illustrated in Fig. 5. In Mbozi district there was an 80% drop in
taeniosis prevalence and a 36% drop in prevalence of porcine cysticercosis from baseline to the last follow-up (S36). In compar-
ison there was a 68% drop in prevalence of taeniosis and a 23% drop in prevalence of porcine cysticercosis in Mbeya. This corre-
sponds to 12 percentage points difference in decrease magnitude of taeniosis prevalence and 13 percentage points difference in
the decrease magnitude of porcine cysticercosis when comparing the two districts.Table 1
Study population characteristics and prevalence of taeniosis in the two districtsMbozi andMbeya during the last 36-month follow-up survey in July/August 2015 (S36).
Survey S36
District Mbozi Mbeya
Stool samples 1517a 1501b
Males % 46 43
Females % 54 57
Children (≤15 years) 1070 1076
Adults (N15 years) 444 425
Taeniosis (%) 9 (0.6) 7 (0.5)
Taeniosis in children (%) 1 (0.1) 4 (0.4)
Taeniosis in adults (%) 8 (1.8) 3 (0.7)
a Age was not recorded for 3 individuals.
b Sex was not recorded for 1 individual.
Fig. 3. Taeniosis prevalence among adult age groups in areas receiving school based MDA in Mbeya and Mbozi district, Tanzania at Feb-Apr 2012 (S0), Jul-Aug
2013 (S12), Jul-Aug 2014 (S24), and Jul-Aug 2015 (S36).
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This is the ﬁrst study to assess the impact of control programmes targeting schistosomiasis on T. solium taeniosis/cysticercosis
measured using both human and porcine outcome variables. The study indicates that a single approach intervention of multiple
rounds of MDA targeting a proportion of the deﬁnitive hosts for T. solium (school aged children) can spill-over into the pig inter-
mediate host population and the untreated adult population. The data presented here further support previous documentation of
the positive effect of MDA and “track-and-treat” among school-aged children (Braae et al., 2015b). However, to which extend the
‘track-and-treat’ contributed to the downward trend is currently not quantiﬁable.
Three studies have been carried out in Latin America using a single MDA of either praziquantel (10 or 5 mg/kg) (Diaz-
Camacho et al., 1991; Sarti et al., 2000) or niclosamide (2 g N 6 years, 1 g b 6 years) (Allan et al., 1997) as the intervention
with the outcome measured both on human and porcine variables. Allan et al. (1997) carried out “track-and-treat” in two com-
munities followed by MDA. The study revealed a drop in both taeniosis based on copro-Ag-ELISA and in porcine cysticercosis
based on enzyme-linked immuneelectrotransfer blot (EITB). However, the study lacked comparison with a control group and op-
tions for assessing different treatment strategies. Sarti et al. (2000) showed a reduction in porcine cysticercosis prevalence based
on EITB after treatment, but saw no signiﬁcant change in taeniosis prevalence based on copro-Ag-ELISA. The study also lacked a
control group or comparison between interventions. Diaz-Camacho et al. (1991) reported a decrease in both taeniosis and porcine
cysticercosis prevalence, but unfortunately this study was based on a small sample size and lacked a control group. Our study is
the ﬁrst from Africa to assess the effect of an existing national control programme on both taeniosis and porcine cysticercosis and
the ﬁrst to show a signiﬁcant effect in both the human and porcine host populations when comparing two treatment groups.Table 2
Porcine study population characteristics, production system practised, and prevalence of porcine cysticercosis, in the two districts Mbozi and Mbeya from ﬁve cross-
sectional surveys during 2012 to 2015.
Survey S0a
Mar/Apr 2012
S3a
Oct/Nov 2012
S12a
Jul/Aug 2013
S24
Jul/Aug 2014
S36
Jul/Aug 2015
District Mbeya Mbozi Mbeya Mbozi Mbeya Mbozi Mbeya Mbozi Mbeya Mbozi
Pigs 408 414 406 406 528 470 474 486 450 537
Sex
Male % 39 43 38 36 39 34 41 39 42 39
Female % 61 57 62 64 61 66 59 61 58 61
Mean age in months (±SD) 7.3 (4.3) 7.5 (4.8) 9.2 (6.8) 8.6 (4.9) 9.8 (6.9) 9.0 (4.8) 9.2 (6.1) 9.6 (6.3) 7.7 (4.5) 8.8 (5.7)
Production system
Conﬁned % 93.3 62.0 92.4 56.4 89.0 59.5 90.9 57.3 95.1 64.0
Semi-conﬁned % 4.2 21.0 3.2 9.1 5.3 27.8 5.1 29.4 4.0 22.8
Free-range % 2.5 17.0 4.4 34.5 5.7 12.6 4.0 13.3 0.9 13.2
Sero-prevalence % 18 13 27 21 21 19 15 12 14 8
a Data have been presented previously on a regional level (Braae et al., 2014).
Fig. 4. Porcine cysticercosis prevalence in the two districts Mbozi and Mbeya, Tanzania at Feb-Apr 2012 (S0), Oct-Nov (S3), Jul-Aug 2013 (S12), Jul-Aug 2014
(S24), and Jul-Aug 2015 (S36). Asterisk (*) marks signiﬁcant difference with baseline (S0) based on logistical regression with *p = 0.01–0.05, **p = 0.001–
0.009, and ***p b 0.0001. Error bars depict the 95% binomial conﬁdence intervals based on number of positives and sample size.
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dren who would not have received as many treatments as the older children. Whereas in Mbozi where no association could be
seen, children were more likely to have received several treatments regardless of their age, since the MDA was carried out annu-
ally compared to biennially in Mbeya. Within the adult population increasing age was a risk factor in both Mbozi and Mbeya, po-
tentially due to increased consumption of pork. To move forward to more comprehensive control of T. solium and ultimately
towards elimination, assessment of the impact of targeting the adult population in either MDA or a more comprehensive
“track-and-treat” is needed.
The prevalence of porcine cysticercosis was consistently lower in Mbozi district compared to Mbeya district despite having sig-
niﬁcantly less pigs conﬁned at the time. This may indicate that other risk factors are important such as pig management leading to
e.g. pigs consuming contaminated feed (Braae et al., 2015a) or water (Komba et al., 2013; Mwanjali et al., 2013).
This study highlights the potential role of MDA as an important tool to control T. solium. However, to reach the WHO goals of
control of T. solium in a foreseeable future (WHO, 2015), additional interventions targeting different stages in the parasite's life
cycle will most likely be required (Gabriël et al., 2016; Johansen et al., 2016). Utilising an existing national control strategyFig. 5. Illustration of the proportional difference in infection of humans and pigs based on prevalence of taeniosis and porcine cysticercosis in Mbozi and Mbeya
districts, Tanzania at baseline carried out in Feb-Apr 2012 (S0) and the last follow-up in Jul-Aug 2015 (S36).
251U.C. Braae et al. / Parasite Epidemiology and Control 1 (2016) 245–251targeting schistosomiasis to support the control of T. solium is likely to be a highly cost-effective approach. However careful as-
sessment of the populations to be targeted in combination with the implementation of additional intervention tools such as health
education and porcine treatment - a One Health approach - is urgently needed to reach the control and elimination goals of these
diseases.
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